|
"chou ah"的相关文件
显示项目 1-25 / 35 (共2页)
1 2 > >>
每页显示[10|25|50]项目
| 國家衛生研究院 |
2015-03 |
Review of enterovirus 71 vaccines
|
Chong, P;Liu, CC;Chow, YH;Chou, AH;Klein, M |
| 國家衛生研究院 |
2014-09-08 |
Long-term immunogenicity studies of formalin-inactivated Enterovirus 71 whole-virion vaccine in macaques
|
Liu, CC;Hwang, CS;Yang, WS;Tsai, DC;Wu, SH;Chou, AH;Chow, YH;Wu, SC;Wang, JR;Chiang, JR;Huang, CC;Pan, CH;Chong, P |
| 國家衛生研究院 |
2014-08-27 |
Delivery of human EV71 receptors by adeno-associated virus increases EV71 infection-induced local inflammation in adult mice
|
Hsiao, HB;Chou, AH;Lin, SI;Lien, SP;Liu, CC;Chong, P;Chen, CY;Tao, MH;Liu, SJ |
| 國家衛生研究院 |
2014-07-30 |
Toll-like receptor 9-mediated protection of enterovirus 71 infection in mice is due to the release of danger-associated molecular patterns
|
Hsiao, HB;Chou, AH;Lin, SI;Chen, IH;Lien, SP;Liu, CC;Chong, P;Liu, SJ |
| 國家衛生研究院 |
2013-12 |
The Madin-Darby canine kidney cell culture derived influenza A/H5N1 vaccine: A Phase I trial in Taiwan
|
Pan, SC;Kung, HC;Kao, TM;Wu, H;Dong, SX;Hu, MH;Chou, AH;Chong, P;Hsieh, SM;Chang, SC |
| 國家衛生研究院 |
2013-11-21 |
Formalin-inactivated EV71 vaccine candidate induced cross-neutralizing antibody against subgenotypes B1, B4, B5 and C4A in adult volunteers
|
Chou, AH;Liu, CC;Chang, JY;Jiang, R;Hsieh, YC;Tsao, A;Wu, CL;Huang, JL;Fung, CP;Hsieh, SM;Wang, YF;Wang, JR;Hu, MH;Chiang, JR;Su, IJ;Chong, PCS |
| 國家衛生研究院 |
2013-11 |
Formulation and immunological evaluation of a trivalent vaccine comprising emulsified submicron particles and inactivated virions of H5N1/EV71/JEV
|
Lin, CW;Chang, CY;Chen, WL;Lin, SC;Liao, CC;Chang, JY;Liu, CC;Yung-Chi Hu, A;Lu, TC;Chou, AH;Wu, SC;Chong, P;Huang, MH |
| 國家衛生研究院 |
2013-05 |
A Phase I, randomized, open-label study to evaluate the safety and immunogenicity of an enterovirus 71 vaccine
|
Cheng, A;Fung, CP;Liu, CC;Lin, YT;Tsai, HY;Chang, SC;Chou, AH;Chang, JY;Jiang, RH;Hsieh, YC;Su, IJ;Chong, PCS;Hsieh, SM |
| 國家衛生研究院 |
2012-12 |
Production of EV71 vaccine candidates
|
Chong, P;Hsieh, SY;Liu, CC;Chou, AH;Yuan, CJ;Wu, SC;Liu, SJ;Chow, YH;Su, IJ;Klein, M |
| 國家衛生研究院 |
2012-11-30 |
Immunological and biochemical characterization of Coxsackie Virus A16 viral particles
|
Chong, P;Guo, MS;Lin, FHY;Hsiao, KN;Weng, SY;Chou, AH;Wang, JR;Hsieh, SY;Su, IJ;Liu, CC |
| 國家衛生研究院 |
2012-09 |
Immunological evaluation and comparison of different EV71 vaccine candidates
|
Chou, AH;Liu, CC;Chang, JY;Lien, SP;Guo, MS;Tasi, HP;Hsiao, KN;Liu, SJ;Sia, C;Wu, SC;Lee, MS;Hsiao, CH;Wang, JR;Chow, YH;Chong, P |
| 國家衛生研究院 |
2012-04 |
Pilot scale production of highly efficacious and stable enterovirus 71 vaccine candidates
|
Chou, AH;Liu, CC;Chang, CP;Guo, MS;Hsieh, SY;Yang, WH;Chao, HJ;Wu, CL;Huang, JL;Lee, MS;Hu, AYC;Lin, SC;Huang, YY;Hu, MH;Chow, YH;Chiang, JR;Chang, JY;Chong, P |
| 國家衛生研究院 |
2012-01 |
Selection and characterization of vaccine strain for Enterovirus 71 vaccine development
|
Chang, JY;Chang, CP;Tsai, HH;Lee, CD;Lian, WC;Ih Jen, S;Sai, IH;Liu, CC;Chou, AH;Lu, YJ;Chen, CY;Lee, PH;Chiang, JR;Chong, PC |
| 國家衛生研究院 |
2011-09 |
Development of a quantitative enzyme linked immunosorbent assay for monitoring the Enterovirus 71 vaccine manufacturing process
|
Liu, CC;Chang, HW;Yang, G;Chiang, JR;Chow, YH;Sai, IH;Chang, JY;Lin, SC;Sia, C;Hsiao, CH;Chou, AH;Chong, P |
| 國家衛生研究院 |
2011-08 |
Presentation of lipopeptide by dendritic cells induces anti-tumor responses via an endocytosis-independent pathway in vivo
|
Song, YC;Chou, AH;Homhuan, A;Huang, MH;Chiang, SK;Shen, KY;Chuang, PW;Leng, CH;Tao, MH;Chong, P;Liu, SJ |
| 國家衛生研究院 |
2011-06 |
Identification and characterization of a cross-neutralization epitope of Enterovirus 71
|
Liu, CC;Chou, AH;Lien, SP;Lin, HY;Liu, SJ;Chang, JY;Guo, MS;Chow, YH;Yang, WS;Chang, KH;Sia, C;Chong, P |
| 國家衛生研究院 |
2011-05 |
Purification and characterization of enterovirus 71 viral particles produced from vero cells grown in a serum-free microcarrier bioreactor system
|
Liu, CC;Guo, MS;Lin, FHY;Hsiao, KN;Chang, KHW;Chou, AH;Wang, YC;Chen, YC;Yang, CS;Chong, PCS |
| 國家衛生研究院 |
2011-01 |
Production of inactivated influenza H5N1 vaccines from MDCK Cells in serum-free medium
|
Hu, YC;Tseng, YF;Weng, TC;Liao, CC;Wu, J;Chou, AH;Chao, HJ;Gu, A;Chen, J;Lin, SC;Hsiao, CH;Wu, SC;Chong, P |
| 國家衛生研究院 |
2010-11 |
Biochemical characterizations of Escherichia coli-expressed protective antigen Ag473 of Neisseria meningitides group B
|
Sung, JWC;Hsieh, SY;Lin, CL;Leng, CH;Liu, SJ;Chou, AH;Lai, LW;Lin, LH;Kwok, Y;Yang, CY;Chong, P |
| 國家衛生研究院 |
2010-08 |
Emulsified nanoparticles containing inactivated influenza virus and CpG oligodeoxynucleotides critically influences the host immune responses in mice
|
Huang, MH;Lin, SC;Hsiao, CH;Chao, HJ;Yang, HR;Liao, CC;Chuang, PW;Wu, HP;Huang, CY;Leng, CH;Liu, SJ;Chen, HW;Chou, AH;Hu, AYC;Chong, PL |
| 國家衛生研究院 |
2010-07 |
A recombinant lipoprotein containing an unsaturated fatty acid activates NF-kappaB through the TLR2 signaling pathway and induces a differential gene profile from a synthetic lipopeptide
|
Leng, CH;Chen, HW;Chang, LS;Liu, HH;Liu, HY;Sher, YP;Chang, YW;Lien, SP;Huang, TY;Chen, MY;Chou, AH;Chong, P;Liu, SJ |
| 國家衛生研究院 |
2009-08 |
Formulation and immunological evaluation of novel vaccine delivery systems based on bioresorbable poly(ethylene glycol)-block-poly(lactide-co-epsilon-caprolactone)
|
Huang, MH;Chou, AH;Lien, SP;Chen, HW;Huang, CY;Chen, WW;Chong, P;Liu, SJ;Leng, CH |
| 國家衛生研究院 |
2009-08 |
Development of multi-phase emulsions based on bioresorbable polymers and oily adjuvant
|
Huang, MH;Huang, CY;Lien, SP;Siao, SY;Chou, AH;Chen, HW;Liu, SJ;Leng, CH;Chong, P |
| 國家衛生研究院 |
2009-05-22 |
Immunological study of HA1 domain of hemagglutinin of influenza H5N1 virus
|
Chiu, FF;Venkatesan, N;Wu, CR;Chou, AH;Chen, HW;Lian, SP;Liu, SJ;Huang, CC;Lian, WC;Chong, P;Leng, CH |
| 國家衛生研究院 |
2009-05 |
Enhancement of potent antibody and T-cell responses by a single-dose, novel nanoemulsion-formulated pandemic influenza vaccine
|
Huang, MH;Huang, CY;Lin, SC;Chen, JH;Ku, CC;Chou, AH;Liu, SJ;Chen, HW;Chong, P;Leng, CH |
显示项目 1-25 / 35 (共2页)
1 2 > >>
每页显示[10|25|50]项目
|
